387 related articles for article (PubMed ID: 31363898)
1. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis.
Liu J; Zhou B; Chen D; Zhou C; Shi Q; Zheng C; Feng G; Yuan F; Ge Y; Xiong B
Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1760-1770. PubMed ID: 31363898
[TBL] [Abstract][Full Text] [Related]
2. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
[TBL] [Abstract][Full Text] [Related]
4. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series.
Zheng D; Yu J; Li H; Gan H; Wang J; Jiang T; Ren H; Wu F
Medicine (Baltimore); 2021 Jul; 100(27):e26610. PubMed ID: 34232216
[TBL] [Abstract][Full Text] [Related]
5. Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study.
Yao W; Liu JC; Wu YJ; Yang CT; Ju SG; Wang YL; Wang CY; Huang SJ; Bai YW; Chen Y; Li TQ; Zhou C; Xiong B
Abdom Radiol (NY); 2022 Oct; 47(10):3615-3627. PubMed ID: 35821274
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of transjugular intrahepatic portosystemic shunt for the treatment of schistosomiasis-induced portal hypertension: a retrospective case series.
Huang S; Liu J; Yao J; Zhao J; Wang Y; Ju S; Wang C; Yang C; Bai Y; Xiong B
Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1090-1097. PubMed ID: 36062499
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
[TBL] [Abstract][Full Text] [Related]
10. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
Liu J; Shi Q; Xiao S; Zhou C; Zhou B; Yuan F; Zheng C; Lin S; Qian K; Feng G; Xiong B
J Gastroenterol Hepatol; 2020 Feb; 35(2):278-283. PubMed ID: 31222830
[TBL] [Abstract][Full Text] [Related]
11. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature.
Nordmann T; Schlabe S; Feldt T; Gobbi F; Krieg A; Bode JG; Fuchs A; Kraef C; Praktiknjo M; Trebicka J; Ramharter M; Addo MM; Strassburg C; Lohse AW; Luedde T; Schmiedel S; Orth HM
PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010065. PubMed ID: 34932562
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
13. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
Wei J; Li H; Li C
J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
[TBL] [Abstract][Full Text] [Related]
16. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.
He FL; Wang L; Yue ZD; Zhao HW; Liu FQ
World J Gastroenterol; 2014 Sep; 20(33):11835-9. PubMed ID: 25206289
[TBL] [Abstract][Full Text] [Related]
17. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
[TBL] [Abstract][Full Text] [Related]
20. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
